acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

09 May 2023

Acarix and the American College of Cardiology collaborate on first edition framework for CADScor System

New York and Washington (May 9, 2023) -- Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaborati...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

03 May 2023

Helen Ljungdahl Round, Acarix President & CEO presents at Redeye Investor Forum

On May 4th at 14.40 Helen Ljungdahl Round, Acarix President & CEO, presents the latest developments in the company at the Redeye In...

Continue reading

acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

03 May 2023

Helen Ljungdahl Round, Acarix VD & koncernchef presenterar på Redeye Investor Forum

Den 4 maj kl 14.40 presenterar Helen Ljungdahl Round, Acarix VD & koncernchef, den senaste utvecklingen i bolaget på Redeye I...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

02 May 2023

Acarix to present at the 2023 Aktiespararna Share Day in Stockholm

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces that the company will present at the 2023 Aktiespararna Share ...

Continue reading

acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

02 May 2023

Acarix presenterar på Aktiespararnas Aktiedag 2023 i Stockholm

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar att bolaget kommer att presentera på Aktiespararnas A...

Continue reading

acarix

Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory

November 18, 2024

02 May 2023

The exercise period for Acarix warrants of series 2022:U begins today

In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrant...

Continue reading

acarix

Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish

November 18, 2024

02 May 2023

Idag inleds nyttjandeperioden för Acarix teckningsoptioner av serie 2022:U

Acarix AB (publ) (“Acarix” eller “Bolaget”) genomförde under december 2022 en företrädesemission...

Continue reading

acarix

Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory

November 18, 2024

11 Apr 2023

Notice of Annual General Meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the annual general meeting to be held on T...

Continue reading

acarix

Corporate Information, General meeting, IR, Listing Regulation, News, Notice, Regulatory, Swedish

November 18, 2024

11 Apr 2023

Kallelse till årsstämma i Acarix AB

Aktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget") kallas härmed till årsstämma torsdagen den 11 maj 2023 kl...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

03 Apr 2023

Acarix accelerates US commercialization into 30 additional states

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced a strategic sales partnership with CompleMed, LLC, a nat...

Continue reading

acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

03 Apr 2023

Acarix accelererar kommersialiseringen i USA till ytterligare 30 delstater

Acarix, ledare inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag ett nytt strategiskt samarbete med CompleMed, en landst...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

14 Mar 2023

Study published in Heart strengthens diagnostic value of Acarix CADScor System

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced the release of a new study published in the March 2023 i...

Continue reading